Korea's Trade Commission Offers Payment To Whistleblowers Reporting Rebates
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In its latest anti-rebate move, South Korea's Fair Trade Commission is offering up to KRW100 million ($82,440) to whistleblowers who uncover illegal rebates offered by pharma companies for sales of their products to hospitals. The new punitive system took effect June 17
You may also be interested in...
Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators
SEOUL - To underscore the government's crackdown on kickbacks ahead of the implementation of a new law on the topic slated to become effective in late November, South Korea's Fair Trade Commission is launching probes of several Korean pharmaceutical firms suspected of providing illicit payments to hospitals and doctors
Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators
SEOUL - To underscore the government's crackdown on kickbacks ahead of the implementation of a new law on the topic slated to become effective in late November, South Korea's Fair Trade Commission is launching probes of several Korean pharmaceutical firms suspected of providing illicit payments to hospitals and doctors
Hospital Bribery Continues In Asia Despite Increased Enforcement
HONG KONG - The use of bribery as a standard business practice in Asia remains a concern for pharma industry observers, despite the fact that more countries are actively enforcing international anti-bribery conventions